IRCT2016091813739N4已完成1 期
Comparing the effects of a-L-Guluronic acid with conventional Non-steroidal anti-inflammatory drugs on disease activity and inflammatory markers in patients with ankylosing spondylitis
Vice-Chancellor for Research, Tehran University of Medical Sciences0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 45 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria: Patients aged 18-45 years old; Diagnosis of Definite AS as defined by the modified New York criteria; Disease activity equal to BASDAI score = 4; Functional activity equal to BASFI score = 4; Each patient must sign written informed consent.
排除标准
- •History of fever and Infectious diseases; Positive pregnancy test or Lactation; Other collagen - vascular diseases; Other auto-immune diseases; Malignancies; Patients have enrolled another clinical trial study within last 4 weeks; Other concomitant diseases (Hepatic, renal, hematological, gastrointestinal, endocrine, cardiovascular, pulmonary, neurological or cerebral disease).
研究者
相似试验
已完成
1 期
The therapeutic effects of a-L-Guluronic acid in patients with Rheumatoid ArthritisRheumatoid Arthritis.Seropositive Rheumatoid ArthritisIRCT2016092813739N5Vice-Chancellor for Research, Tehran University of Medical Sciences36
已完成
1 期
The therapeutic effect of Glucuronic acid in breast cancer patientsCondition 1: Breast Cancer. Condition 2: Breast Cancer. Condition 3: Breast Cancer. Condition 4: Breast Cancer. Condition 5: Breast Cancer. Condition 6: Breast Cancer. Condition 7: Breast Cancer. Condition 8: Breast Cancer.Malignant neoplasm: overlapping lesion of breastMalignant neoplasm: upper-inner quadrant of breastMalignant neoplasm: lower-inner quadrant of breastMalignant neoplasm: upper-outer quadrant of breastMalignant neoplasm: lower-outer quadrant of breastMalignant neoplasm: axillary tail of breastMalignant neoplasm: breast, unspecifiedMalignant neoplasm: nipple and areolaIRCT2017061113739N9Vice-Chancellor for Research, Tehran University of Medical Sciences36
尚未招募
3 期
Evaluation of efficacy and safety of Glurunic acid (G2013) in patients with COVID-19COVID-19.Covid-19U07.1IRCT20080901001165N64Ministry of Defense, Department of Health180
已完成
不适用
Effects of oral administration of lauric acid on gut hormone release and appetite perceptions in healthy peopleType 2 diabetesHealthy Human Gastrointestinal PhysiologyDiet and Nutrition - ObesityOral and Gastrointestinal - Normal oral and gastrointestinal development and functionMetabolic and Endocrine - DiabetesObesityACTRN12619000075189Prof. Christine Feinle-Bisset10
已完成
不适用
Treatment of Acne scarsCTRI/2018/02/012050Andrea Rosario30